Dr. Reddy's Russian Subsidiary Gets Major Relief as Penalty Reduced to Rs 11.40 Million:

Dr. Reddy's Russian Subsidiary Gets Major Relief as Penalty Reduced to Rs 11.40 Million Dr. Reddy's Laboratories Ltd has recently disclosed to the stock exchanges that its Russian Subsidiary company, Dr. Reddy’s Laboratories LLC, Russia, has received a final penalty decision from the Russian tax authority.

Background of the Case

As per Dr. Reddy's Laboratories, the russian tax authority has reclassified marketing services as taxable services, levying VAT (Value Added Tax). Based on this reclassification, the tax authority imposed a penalty.

Also Read

Apollo Tyres Faces GST Penalty for E-way Bill, Says No Major Financial Impact

The previous original penalty was higher, but in the final decision, the penalty was reduced. The original penalty was RUB 20.09 million (Rs 24.50 million), which has been slashed to RUB 9.27 million (Rs 11.40 million).

Key Details of Order

Particulars	Details
Company	Dr. Reddy’s Laboratories Ltd
Subsidiary	Dr. Reddy’s Laboratories LLC, Russia
Authority	Interdistrict Inspectorate, Federal Tax Service of Russia
Original Penalty	RUB 20.09 million (Rs 24.50 million)
Final Penalty	RUB 9.27 million (Rs 11.40 million)
Order Date	April 13, 2026

Financial Impact

Dr. Reddy's Laboratories clarified that, based on its evaluation, the penalty does not have any significant impact on its financials, operations, or other activities.

Also Read

Torrent Power Faces Rs 189 Crore Tax Demand and Penalty; Plans to Contest Order

Company's Disclosure Requirement

The above disclosure was made by Dr. Reddy’s Laboratories Limited on April 14, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, in furtherance to its earlier disclosure dated January 24, 2026.